Position
Squarepoint Ops LLC in Axsome Therapeutics, Inc.
Back to the book · All holders of AXSM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.55M$182.64 → $169.02
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 155K | $28.3M | — | — | — | 0.0% |
| Q1 2026 | 114.1K | $19.3M | $169.02 | −$1.55M | −$7.47M | 0.0% |